Anal Cancer Trial Results
- Electrocautery Superior to Topical Treatments for Precancerous Anal Lesions
(Posted: 04/04/2013) - Results from a randomized clinical trial conducted in Amsterdam suggest that electrocautery is better than topical imiquimod or fluorouracil at treating potentially precancerous anal lesions in HIV-positive men who have sex with men.
- Vaccine Reduces HPV Infections in Young Men
(Posted: 03/29/2011) - An international randomized clinical trial has shown that the vaccine Gardasil can reduce the incidence of anogenital human papillomavirus (HPV) infections in young men 16 to 26 years of age at the time of vaccination.
- Cisplatin No Better than Standard Therapy for Anal Canal Cancer
(Posted: 04/30/2008) - Replacing mitomycin with cisplatin in chemoradiotherapy for cancer of the anal canal failed to improve either disease-free or overall survival and resulted in more patients needing colostomies, according to a study in the April 23, 2008, Journal of the American Medical Association.